Symptomtext
Immediate onset of severe Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6202) via an unspecified route of administration in the left arm on 04Mar2021 at 08:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included tentative diagnosis of otosclerosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin calcium (CRESTOR), acetylsalicylic acid (ASPIRIN), famotidine (PEPCID AC) and oxazepam (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 06Mar2021 at 10:00, the patient experienced immediate onset of severe tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of immediate onset of severe tinnitus, visited to ENT on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event immediate onset of severe tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.